Mechanisms and Functions of ATR signaling
Mechanisms and Functions of ATR signaling
批准号:
10347345
负责人:
David K Cortez
金额:
$46.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2024-03-31
关键词:
Antineoplastic AgentsAreaBindingBiochemicalBiochemical GeneticsCell CycleCell Cycle RegulationCell SurvivalCellsChromosome SegregationClinicClinicalClinical TrialsComplexDNA DamageDNA RepairDNA biosynthesisDNA replication forkDataData SetDefectDependenceDevelopmentDimerizationDrug TargetingExcisionExhibitsGenesGeneticGenetic studyGenomeGenome StabilityGoalsInvestigationKnowledgeLaboratoriesLeadLinkMaintenanceMalignant NeoplasmsMass Spectrum AnalysisMethodsMitosisModelingMutateMutationOncogenesOutcomePathway interactionsPharmaceutical PreparationsPhosphotransferasesProteinsProteomeProteomicsRecyclingRegulationReplication InitiationResearchSignal PathwaySignal TransductionSurfaceTOPBP1 GeneTREX1 geneTertiary Protein StructureTestingThree Prime Repair Exonuclease 1TranslatingWorkbasebiological adaptation to stresscancer cellcancer therapyclinical effectexpectationexperimental studygenetic approachgenome integrityimmune checkpointinhibitorinnovationinsightloss of functionphosphoproteomicsprematurepreservationpreventprotein functionreplication stressresponsestructural biologysynergism
中文摘要
项目摘要
这项拟议研究的长期目标是了解细胞如何保持基因组的完整性。
具体地说,这个应用程序主要关注ATR(ATM和Rad3相关)信号通路。ATR功能位于
DNA损伤和复制应激反应通路的顶点,这是每个细胞分裂周期都需要的
促进基因组完全精准复制。许多癌细胞高度依赖于
由于癌基因诱导的复制应激水平升高,ATR对增殖和生存能力具有作用
以及其他基因组维持途径的突变。因此,ATR可能是一个有用的药物靶点,基于
合成致命方法。ATR抑制剂目前正在各种癌症环境中进行临床试验。我们
先前发现,TOPBP1或ETAA1形成了两个独立的ATR信号复合体。在……里面
在这项建议中,我们研究了这些替代ATR复合体的功能,探索这些蛋白质如何
激活ATR,并研究如何对ATR进行监管以应对不同类型的复制挑战。这
是一项旨在了解ATR最重要和最不被理解的方面的重点提案
功能。基于初步数据的特定假设和创新概念使用高级
生物化学和遗传方法。此外,这些目标还为意外发现提供了机会
关于维持基因组的机制以及ATR途径抑制剂何时可能在
癌症诊所。
英文摘要
Project Summary
The long-term goal of the proposed research is to understand how cells preserve genome integrity.
Specifically, this application focuses on the ATR (ATM and rad3-related) signaling pathway. ATR functions at
the apex of a DNA damage and replication stress response pathway that is needed every cell division cycle to
promote the complete and accurate duplication of the genome. Many cancer cells are highly dependent on
ATR function for proliferation and viability because of elevated levels of oncogene-induced replication stress
and mutations in other genome maintenance pathways. Thus, ATR may be a useful drug target based on a
synthetic lethal approach. ATR inhibitors are currently in clinical trials in a variety of cancer settings. We
previously found that there are two independent ATR signaling complexes formed by TOPBP1 or ETAA1. In
this proposal we examine the functions of these alternative ATR complexes, explore how these proteins
activate ATR, and examine how ATR is regulated in response to different types of replication challenges. This
is a focused proposal aimed at understanding the most important and least understood aspects of ATR
function. Specific hypotheses and innovative concepts based on preliminary data are tested using advanced
biochemical and genetic approaches. In addition, the aims provide opportunities for unexpected discoveries
about the mechanisms that maintain the genome and when ATR pathway inhibitors may be useful in the
cancer clinic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions of SRAP domain proteins in DNA metabolism
-
批准号:10318157
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
Mechanisms and Functions of ATR signaling
-
批准号:9898336
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
Functions of SRAP domain proteins in DNA metabolism
-
批准号:9901531
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
Functions of SRAP domain proteins in DNA metabolism
-
批准号:9751009
-
项目类别:
-
资助金额:$43.76万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
Functions of SRAP domain proteins in DNA metabolism
-
批准号:10541820
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
Mechanisms and Functions of ATR signaling
-
批准号:10132270
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
Mechanisms and Functions of ATR signaling
-
批准号:10565859
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2019
-
负责人:David K Cortez
-
依托单位:
2017 Mammalian DNA Repair Gordon Research Conference & Gordon Research Seminar
-
批准号:9261069
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2017
-
负责人:David K Cortez
-
依托单位:
Function of the ATR-ATRIP complex
-
批准号:8967327
-
项目类别:
-
资助金额:$1.14万
-
财政年份:2015
-
负责人:David K Cortez
-
依托单位:
Analysis of the Replication Stress Response
-
批准号:10225410
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2015
-
负责人:David K Cortez
-
依托单位:
Analysis of the Replication Stress Response
-
批准号:10733050
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:David K Cortez
-
依托单位:
Analysis of the Replication Stress Response
-
批准号:9815242
-
项目类别:
-
资助金额:$43.8万
-
财政年份:2015
-
负责人:David K Cortez
-
依托单位:
Analysis of the Replication Stress Response
-
批准号:10457828
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2015
-
负责人:David K Cortez
-
依托单位:
Analysis of the Replication Stress Response
-
批准号:10004147
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2015
-
负责人:David K Cortez
-
依托单位:
SMARCAL1 function in replication stress and disease
-
批准号:8517046
-
项目类别:
-
资助金额:$44.47万
-
财政年份:2012
-
负责人:David K Cortez
-
依托单位:
SMARCAL1 function in replication stress and disease
-
批准号:8850250
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2012
-
负责人:David K Cortez
-
依托单位:
SMARCAL1 function in replication stress and disease
-
批准号:9249756
-
项目类别:
-
资助金额:$47.49万
-
财政年份:2012
-
负责人:David K Cortez
-
依托单位:
Mechanisms of DNA replication and repair
-
批准号:8581644
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2012
-
负责人:David K Cortez
-
依托单位:
Mechanisms of DNA replication and repair
-
批准号:8427083
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2012
-
负责人:David K Cortez
-
依托单位:
SMARCAL1 function in replication stress and disease
-
批准号:8369291
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2012
-
负责人:David K Cortez
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: